SCHEMBL4958817

SCHEMBL4958817

O=C(Nc1nc2c(s1)Cc1cc(F)ccc1-2)c1cnccc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 15/20 0.52
ALDH1A1 P00352 6/20 0.52
TP53 P04637 6/20 0.52
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
BLM P54132 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
THRB P10828 4/20 0.49
SMN1; SMN2 Q16637 6/20 0.48
APAF1 O14727 4/20 0.48
TDP2 O95551 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
CASP3 P42574 1/20 0.48
MCL1 Q07820 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4957466 0.78 POLB (0.61) MAPTALDH1A1TP53MEN1KMT2A
SCHEMBL4958307 0.77 MAPT (0.71) MAPTALDH1A1TP53MEN1KMT2A
SCHEMBL4958208 0.77 POLB (0.54) MAPTALDH1A1TP53MEN1KMT2A
SCHEMBL4963945 0.76 MAPT (0.60) MAPTALDH1A1TP53MEN1KMT2A
SCHEMBL4957199 0.76 MAPT (0.61) MAPTALDH1A1TP53MEN1KMT2A
SCHEMBL4958350 0.72 MAPT (0.68) MAPTALDH1A1TP53MEN1KMT2A
SCHEMBL4958725 0.70 ADORA1 (0.60) MAPTALDH1A1TP53MEN1KMT2A
SCHEMBL4960364 0.70 MAPT (0.73) MAPTALDH1A1TP53MEN1KMT2A
SCHEMBL4958411 0.69 MAPT (0.57) MAPTALDH1A1TP53MEN1KMT2A
SCHEMBL4960241 0.69 ADORA1 (0.61) MAPTALDH1A1TP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7407977-B2 Substituted N-acyl-2-aminothiazoles HOFFMAN-LA ROCHE INC. (US) 2008-08-05 US claimed
CN-1993336-A Substituted n-acyl-2-aminothiazoles HOFFMANN LA ROCHE (CH) 2007-07-04 CN claimed
EP-1791822-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F.HOFFMANN-LA ROCHE AG (CH) 2007-06-06 EP claimed
US-20060030589-A1 Substituted N-acyl-2-aminothiazoles HOFFMANN-LA ROCHE INC. 2006-02-09 US claimed
WO-2006013054-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2006-02-09 WO claimed
US-7407977-B2 Substituted N-acyl-2-aminothiazoles HOFFMAN-LA ROCHE INC. (US) 2008-08-05 US disclosed
CN-1993336-A Substituted n-acyl-2-aminothiazoles HOFFMANN LA ROCHE (CH) 2007-07-04 CN disclosed
EP-1791822-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F.HOFFMANN-LA ROCHE AG (CH) 2007-06-06 EP disclosed
US-20060030589-A1 Substituted N-acyl-2-aminothiazoles HOFFMANN-LA ROCHE INC. 2006-02-09 US disclosed
WO-2006013054-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2006-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030589-A1 Substituted N-acyl-2-aminothiazoles SLC5A2, ABAT, AGTR2 MAPT 1360/4885ALDH1A1 491/4885TP53 4777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.